Recurrent pleomorphic adenoma of the parotid gland.
This is a retrospective analysis of 35 patients treated for a first recurrence of pleomorphic adenoma of the parotid gland from 1982 to 1997. All patients were treated surgically; no patient received radiotherapy for benign disease. We experienced a locoregional control rate of 77%. Our malignant transformation rate was 5.7%. Our results suggest that in carefully selected patients, local excision of recurrent disease is sufficient in controlling further recurrence.
Maxwell
Evelyn Linda
EL
Department of Otolaryngology Head Neck Surgery, University of Toronto, Mount Sinai Hospital, Toronto, ON.
Hall
Francis T
FT
Freeman
Jeremy L
JL
D008949:Adenoma, Pleomorphic / Q000453:epidemiology* / Q000601:surgery; D000328:Adult; D000368:Aged; D002471:Cell Transformation, Neoplastic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology* / Q000601:surgery; D009864:Ontario / Q000453:epidemiology; D010306:Parotid Gland / Q000601:surgery; D010307:Parotid Neoplasms / Q000453:epidemiology* / Q000601:surgery; D010614:Pharynx / Q000601:surgery; D012086:Reoperation / Q000706:statistics & numerical data; D012189:Retrospective Studies